Results 181 to 190 of about 141,694 (266)

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity

open access: yesImmunological Reviews, Volume 340, Issue 1, July 2026.
ABSTRACT Advances in high‐throughput sequencing, single‐cell profiling, and genome engineering have transformed the study of T cell receptors (TCRs), enabling the identification and functional interrogation of antigen‐specific repertoires at an unprecedented scale.
Kilian Schober
wiley   +1 more source

Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 7, July 2026.
ABSTRACT The epidemiological landscape of paired hepatitis B virus (HBV)/hepatitis delta virus (HDV) genotype (GT) among patients with HDV in the US remains unknown. HBV/HDV genotypes were assessed in two independent US cohorts: Cohort 1 included 5222 HBV‐positive patients from Quest Diagnostics, including 114 anti‐HDV+ patients; Cohort 2 included 178 ...
Andrew Lopez   +17 more
wiley   +1 more source

Burnt‐Out MASLD Predicts Outcomes After Curative Resection for Hepatocellular Carcinoma

open access: yesLiver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims Hepatic steatosis often diminishes as metabolic dysfunction–associated steatotic liver disease (MASLD) progresses, leading to a so‐called ‘burnt‐out’ state. Whether this phenotype simply reflects advanced liver injury or represents a biologically distinct condition with prognostic relevance after hepatocellular carcinoma ...
Yukihiro Watanabe   +10 more
wiley   +1 more source

How Epstein–Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons

open access: yes
MedComm, Volume 7, Issue 7, July 2026.
Dan Liu, Wenhui Fan, Pengtao Jiao
wiley   +1 more source

Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates

open access: yesLiver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims Reliable data on viral hepatitis–related deaths remain limited, challenging assessment of progress towards the WHO elimination targets for mortality. To address this gap, we estimated hepatitis B‐ and C‐attributable mortality in Italy, Romania, and Spain for 2022.
Oleksandr Korotych   +54 more
wiley   +1 more source

Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring

open access: yesLiver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims Chronic hepatitis D is the most severe form of viral hepatitis. Despite recommendations for systematic screening of HBsAg‐positive individuals, hepatitis D infection remains underdiagnosed. Standard HDV virological markers are classically assessed in serum or plasma specimens obtained through venous whole blood sampling ...
Rola Matar   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy